/Richard Christopher/ - 31 Aug 2024 Form 3 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Executive Officer
Signature
/Richard Christopher/
Issuer symbol
LEXX
Transactions as of
31 Aug 2024
Net transactions value
$0
Form type
3
Filing time
05 Sep 2024, 13:09:38 UTC
Previous filing
21 Nov 2022
Next filing
03 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 31 Aug 2024 Common Shares 200,000 $3.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options are vested as to 50,000 on February 28, 2025 with 6,818 being vested monthly thereafter until November 30, 2026 whereby the balance of 6,822 options will be vested on December 31, 2026